Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2012
05/01/2012US8170808 Methods and computer software for detecting splice variants
05/01/2012US8170806 Methods of populating data structures for use in evolutionary simulations
05/01/2012US8170805 Method for selecting statistically validated candidate genes
05/01/2012US8170804 Determination of melting temperatures of DNA
05/01/2012US8168854 Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression
05/01/2012US8168773 Methods for monitoring multiple gene expression
05/01/2012US8168772 Nucleic acids encoding novel chimeric C15/prM/E dengue virus immunogens prepared by DNA shuffling
05/01/2012US8168768 Methods for monitoring multiple gene expression
05/01/2012US8168610 Bispecific oligonucleotide for the treatment of CNS malignancies
05/01/2012US8168606 RNAi inhibition of alpha-ENaC expression
05/01/2012US8168603 G-quartet oligonucleotides that target hypoxia-inducible factor 1-α (HIF1α)
05/01/2012US8168586 Cancer targets and uses thereof
05/01/2012US8168430 Method for preparation of hepatocyte using ES cell
05/01/2012US8168423 Device for detecting nitrosothiol content in solution
05/01/2012US8168417 Bacillus licheniformis chromosome
05/01/2012US8168408 Cytolethal distending toxins and detection of Campylobacter bacteria using the same as a target
05/01/2012US8168406 Dry analytical element for lipase measurement
05/01/2012US8168405 Covalent tethering of functional groups to proteins and substrates therefor
05/01/2012US8168394 GAG protein immunoglobulin fusion for use in detection of hepatitis C virus and human immunodeficiency viral infection
05/01/2012US8168392 Tetrahydrofolate synthetase gene
05/01/2012US8168391 Method for modulating insulin production
05/01/2012US8168390 Method and apparatus for diagnosing age-related macular degeneration
05/01/2012US8168389 Fetal cell analysis using sample splitting
05/01/2012US8168388 Preparation of nucleic acid templates for solid phase amplification
05/01/2012US8168387 Oligonucleotides, use thereof, detecting method and kit for diagnosing the presence of H5 and N1 genes of the Influenza A virus
05/01/2012US8168386 Methods for detecting Venezuelan equine encephalitis virus TC-83 and its use as a biological agent simulant
05/01/2012US8168385 Methods and compositions for tagging and identifying polynucleotides
05/01/2012US8168384 Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy
05/01/2012US8168383 Gene defects and mutant ALK kinase in human solid tumors
05/01/2012US8168382 Methods for detecting DNA originating from different individuals
05/01/2012US8168381 Template directed split and mix systhesis of small molecule libraries
05/01/2012US8168380 Methods and products for analyzing polymers
05/01/2012US8168205 Streptococcus pneumoniae polypeptides
05/01/2012US8168187 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer
05/01/2012US8168179 Treatment method using anti-PD-L1 antibody
05/01/2012US8168052 Transition metal complexes with bidentate ligand having an imidazole ring
05/01/2012US8168051 Sensor for determination of glucose
05/01/2012CA2653794C Method of detecting preeclampsia
05/01/2012CA2558012C Animals with reduced body fat and increased bone density
05/01/2012CA2551267C Universal amplification of fragmented rna
05/01/2012CA2518147C Optically decodable microcarriers, arrays and methods
05/01/2012CA2473566C Pim-3 kinase as a target for type 2 diabetes mellitus
05/01/2012CA2472970C New detection format for hot start real time polymerase chain reaction
05/01/2012CA2438080C Gonococcal proteins and nucleic acids
05/01/2012CA2429625C Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof
05/01/2012CA2428431C System and method for integrated analysis of data for characterizing carbohydrate polymers
05/01/2012CA2390891C Method for diagnosing a transmissible spongiform subacute encephalopathy caused by an unconventional transmissible agent strain in a biological sample
05/01/2012CA2381144C In vivo high throughput toxicology screening method
05/01/2012CA2365555C Genetically modified plants having modulated brassinosteroid signaling
05/01/2012CA2335318C Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
05/01/2012CA2333466C Gbs toxin receptor
05/01/2012CA2322763C Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial uc panca antigens
05/01/2012CA2279555C Amyloid beta protein (globular assembly and uses thereof)
05/01/2012CA2169524C Dna sequence coding for an a.thaliana protein with delta-5,7 sterol, delta-7 reductase, delta-7-red protein activity, process for producing the same, transformed yeast strains, uses
04/2012
04/29/2012CA2719597A1 Methods and apparatus for nanoparticle-assisted nucleic acid hybridization and microarray analysis
04/26/2012WO2012054933A2 Universal probe assay methods
04/26/2012WO2012054915A2 Homozygous and heterozygous idh1 gene-defective human astrocytoma cell lines
04/26/2012WO2012054873A2 Varietal counting of nucleic acids for obtaining genomic copy number information
04/26/2012WO2012054809A2 Rapid high resolution, high throughput rna structure, rna-macromolecular interaction, and rna-small molecule interaction mapping
04/26/2012WO2012054795A1 An ultra sensitive method for in situ detection of nucleic acids
04/26/2012WO2012054735A2 Systems and methods for assessing biomolecule characteristics
04/26/2012WO2012054730A1 Methods and kits for detection of 5-hydroxymethylcytosine
04/26/2012WO2012054726A1 Lactococcus crispr-cas sequences
04/26/2012WO2012054723A2 Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua
04/26/2012WO2012054681A2 Methods for selecting medications for treating patients having attention-deficit hyperactivity disorder
04/26/2012WO2012054654A2 Anti-folate receptor alpha antibody glycoforms
04/26/2012WO2012054653A2 Diagnostic kits, genetic markers, and methods for scd or sca therapy selection
04/26/2012WO2012054641A2 Hydrodynamic particle separation and detection systems and methods
04/26/2012WO2012054321A2 Assays, methods and kits for predicting renal disease and personalized treatment strategies
04/26/2012WO2012054284A2 Interferon gene signature and methods of use thereof
04/26/2012WO2012054028A1 Method of calibrating and correcting color-bleed factors for color separation in dna analysis
04/26/2012WO2012053893A1 Method to produce milk with increased unsaturated fatty acids content
04/26/2012WO2012053850A2 Detection of target nucleic acid sequences using dual-labeled immobilized probes on solid phase
04/26/2012WO2012053666A1 Kit for detecting bovine leukemia virus(blv), and use thereof
04/26/2012WO2012053622A1 Non-human animal, cell, method for evaluation of blood pressure regulator, method for evaluation of condition for regulation of blood pressure, and method for regulation of blood pressure
04/26/2012WO2012053305A1 Marker for amyotrophic lateral sclerosis, and use thereof
04/26/2012WO2012053138A1 Method for immobilizing glucose oxidase on self-assembled film
04/26/2012WO2012053018A1 Method f or the detection of biological reactions products
04/26/2012WO2012052954A1 Signatures of clinical outcome in gastro intestinal stromal tumors and method of treatment of gastroinstestinal stromal tumors
04/26/2012WO2012052913A1 Process for treatment of residual nucleic acids present on the surface of laboratory consumables
04/26/2012WO2012052844A1 Methods and biomarkers for detection of bladder cancer
04/26/2012WO2012052758A1 Response biomarkers for iap antagonists in human cancers
04/26/2012WO2012052711A1 Method for identifying activation of transferases
04/26/2012WO2012052684A1 Method for detection of irreversible dna damage and measurement of the genotoxic effects of agents on early developmental stages of whole organisms
04/26/2012WO2012052594A2 USE OF Dlk1 AS AN ANGIOGENESIS INHIBITOR
04/26/2012WO2012052566A1 Sensor
04/26/2012WO2012052539A1 Novel neutral (bio)material
04/26/2012WO2012052526A1 Use of specific genes or their encoded proteins for a prognosis method of classified lung cancer
04/26/2012WO2012052524A1 Use of specific genes for the prognosis of lung cancer and the corresponding prognosis method
04/26/2012WO2012052189A1 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
04/26/2012WO2012052181A1 A conjugate between a thiophilic solid phase and an oligonucleotide comprising a thiooxonucleotide
04/26/2012WO2012051800A1 Plasmid standard for use in quantitative assays using fluorescent quantitative pcr
04/26/2012WO2012051644A1 Compostion and apparatus for detecting urease in gastric contents
04/26/2012WO2012028958A3 Antibody for colorectal cancer marker
04/26/2012WO2012024255A3 Camkk-beta as a target for treating cancer
04/26/2012WO2012018741A3 Pressurizable cartridge for polymerase chain reactions
04/26/2012WO2012018397A3 Molecular subtyping of oral squamous cell carcinoma to distinguish a subtype that is unlikely to metastasize
04/26/2012WO2012012725A3 Methods of detecting diseases or conditions using phagocytic cells
04/26/2012WO2012009425A3 In vitro pharmacokinetics/pharmacodynamics bellows perfusion system for enhancing effectiveness of cancer chemotherapy
04/26/2012WO2012006421A3 Diagnosis and treatment of breast cancer